---
title: "NHS National Framework for Romiplostim"
ocid: "ocds-h6vhtk-07b8f6"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07b8f6"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-07b8f6.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-07b8f6.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "NHS England"
published: "2026-11-10"
---

# NHS National Framework for Romiplostim

Buyer: NHS England  
Current stage: Planning  
OCID: ocds-h6vhtk-07b8f6

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07b8f6)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-07b8f6.json)

## Summary

NHS England intends to establish a national framework for romiplostim, a pharmaceutical product. The procurement is for the medicine rather than a broader clinical service. Delivery is planned across parts of England: the North East, North West, East Midlands, West Midlands, East of England, South East and South West. NHS England is the buying organisation. The planned framework is relevant to pharmaceutical manufacturers and suppliers with romiplostim in their product range, including businesses preparing to introduce the medicine. The buyer has specifically invited suppliers planning to introduce the molecule covered by the framework to make contact about the forthcoming procurement. This is a national NHS purchasing arrangement for a defined medicine, not a general medicines supply contract.

This process is at the planning stage: NHS England has signalled an intention to procure, and there is no invitation to tender yet. The buyer expects to use an open procedure and a framework agreement. The planned contract period is 2028, with possible extension through to the end of 2030. NHS England expects the next notice on 4 May 2027; this is an indicative publication date, not a bid deadline. The estimated value is £50.4 million excluding VAT (£60.48 million including VAT). The procurement is planned as a single lot, with the lot marked suitable for small and medium-sized businesses. The published information does not set out evaluation criteria or detailed participation requirements.

This framework is most relevant to pharmaceutical companies that manufacture, market or distribute romiplostim, especially suppliers intending to introduce the medicine to the market. It may suit smaller suppliers as well as larger firms, since the planned lot is identified as suitable for SMEs. Suppliers should consider whether they can support supply across the listed English regions and meet the operational demands of a national NHS framework. The buyer has invited engagement from suppliers planning to introduce the molecule, so businesses with a relevant product pipeline may wish to prepare questions or share information with NHS England’s new market developments team ahead of the procurement. The planning information does not identify particular accreditations, technical capabilities or experience requirements.

## Notice

Project title: NHS National Framework for Romiplostim Offer reference number: CM/TNS/26/5769 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, markcartwright@nhs.net and katie.noonan@nhs.net

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/106851-2026 |
| Notice type | UK1 - Pipeline Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | SME |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 10 Nov 2026 |
| Submission deadline | Not specified |
| Future notice date | 4 May 2027 |
| Award date | Not specified |
| Contract period | 1 Jan 2028 - 31 Dec 2028 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £50,400,000 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planned |
| Lots status | Planned |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS England |
| Locality | LONDON |
| Postcode area | South East London |
| Postcode | SE1 8UG |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England) |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 10 Nov 2026 at 16:28 - Planning - UK1 - Pipeline Notice - https://www.find-tender.service.gov.uk/Notice/106851-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/106851-2026
  10th November 2026 - Pipeline notice on Find a Tender

## Notice URLs

- https://www.england.nhs.uk/
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07b8f6. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-07b8f6.json.
